Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study

Figure 3

Sociodemographic and clinical factors associated with receipt of first-line bevacizumab: multivariable logistic regression model results #. #n = 352. Three patients were excluded due to missing explanatory variables. Model results incorporate formal adjustments for multiple imputations of missing data. OR's and CI's are plotted on a log scale. Comorbidity was calculated using the Adult Comorbidity Evaluation-27 Scale. Abbreviations: OR, adjusted odds ratio; CI, confidence interval; ATL, Atlantic; SOU, Southern; WMW, West/Midwest. *P-values for aggregate variable effects (type 3 Wald statistics) are listed next to each variable category in the left-hand column.

Back to article page